Literature DB >> 19144669

Current pharmacotherapeutic concepts for the treatment of obesity in adults.

Evgeny Idelevich1, Wilhelm Kirch, Christoph Schindler.   

Abstract

Obesity is one of the greatest public health challenges of the twenty-first century. The World Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were overweight and at least 400 million adults were obese. The prevalence of obesity is still continuing to increase dramatically. Overweight and obese people carry a higher risk for a variety of cardiovascular diseases including hypertension, coronary heart disease, stroke and peripheral occlusive artery disease. Weight loss is considered to be the initial step which helps to prevent or to control the clinical consequences of obesity. In a great number of patients who are not able to reduce weight by means of non-pharmacological measures, drug therapy can assist in reaching the weight management targets. Drug treatment should only be considered as part of a systematic weight management program including dietary and lifestyle changes. This review summarizes current pharmacotherapeutic concepts for the treatment of obesity in adults focusing on efficacy and safety of anti-obesity drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19144669     DOI: 10.1177/1753944708098226

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  7 in total

1.  A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.

Authors:  Kirstin F Barnhart; Dawn R Christianson; Patrick W Hanley; Wouter H P Driessen; Bruce J Bernacky; Wallace B Baze; Sijin Wen; Mei Tian; Jingfei Ma; Mikhail G Kolonin; Pradip K Saha; Kim-Anh Do; James F Hulvat; Juri G Gelovani; Lawrence Chan; Wadih Arap; Renata Pasqualini
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

2.  Beneficial impact of aerobic exercises on bone mineral density in obese premenopausal women under caloric restriction.

Authors:  Iman Abbas Hosny; Hamed Samir Elghawabi; Wael Bahat Fahmy Younan; Adly Aly Sabbour; Mona Abdel Messih Gobrial
Journal:  Skeletal Radiol       Date:  2011-05-24       Impact factor: 2.199

Review 3.  Metabolic rate regulation by the renin-angiotensin system: brain vs. body.

Authors:  Justin L Grobe; Kamal Rahmouni; Xuebo Liu; Curt D Sigmund
Journal:  Pflugers Arch       Date:  2012-04-12       Impact factor: 3.657

Review 4.  What are the risks and the benefits of current and emerging weight-loss medications?

Authors:  Jamie R Robinson; Kevin D Niswender
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

5.  Pharmacotherapies for obesity: past, current, and future therapies.

Authors:  Lisa L Ioannides-Demos; Loretta Piccenna; John J McNeil
Journal:  J Obes       Date:  2010-12-12

6.  Clinical and economic considerations of antiobesity treatment: a review of orlistat.

Authors:  Armineh Zohrabian
Journal:  Clinicoecon Outcomes Res       Date:  2010-07-05

7.  Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.

Authors:  Gemma Nicoll; Scott Davidson; Lynne Shanley; Ben Hing; Marissa Lear; Peter McGuffin; Ruth Ross; Alasdair MacKenzie
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.